.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M03B_MuscleRelaxantsCentrallyActingAgents.M03BA02_Carisoprodol.Carisoprodol

Information

Carisoprodol is a centrally acting skeletal muscle relaxant that blocks pain sensations between the nerves and the brain. It is primarily used for the short-term relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol is a controlled substance due to its potential for abuse and dependence; in many countries, its use has been reduced or discontinued. In the United States, carisoprodol remains approved for prescription use for up to two or three weeks at a time.

Pharmacokinetics

Pharmacokinetic parameters reported in healthy adult volunteers following single oral administration.

References

1. Heltsley, R, et al., & Cone, EJ (2011). Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. Journal of analytical toxicology 35(8) 529–540. DOI:10.1093/anatox/35.8.529 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22004671

Revisions

• 06/2025 initial generated model